Kingstone Cos., Inc.

{
  "main_header": {
    "sid": 1156598,
    "name": "Kingstone Cos., Inc.",
    "stock_name": "Kingstone Cos., Inc.",
    "full_name": "Kingstone Cos., Inc.",
    "name_url": "stocks-analysis/kingstone-cos-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "16.05",
    "chg": -0.08,
    "chgp": "-0.5%",
    "dir": -1,
    "prev_price": "16.13",
    "mcapval": "226.50",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Capital Markets",
    "ind_code": 4880,
    "indexname": "S&P 500",
    "isin": "US4967191051",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "313.91 k",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kingstone-cos-inc-1156598-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Kingstone Cos., Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kingstone-cos-inc-overvalued-or-undervalued-3728362",
        "imagepath": "",
        "date": "2025-11-25 11:15:03",
        "description": "As of 21 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to Sales ratio of 1.25. In comparison to peers, Crawford & Co. has a higher P/E of 17.88, while GoHealth, Inc. shows a significantly lower P/E of 2.12, indicating that Kingstone is positioned between these two companies in terms of valuation.\n\nWhile Kingstone has experienced a remarkable 3-year return of 1520.70%, it has underperformed relative to the S&P 500 over the past year, with a return of -2.64% compared to the index's 11.00%. This suggests that although the company has had strong historical performance, its current valuation does not reflect the same growth potential moving forward...."
      },
      {
        "title": "Is Kingstone Cos., Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kingstone-cos-inc-overvalued-or-undervalued-3723355",
        "imagepath": "",
        "date": "2025-11-23 11:10:45",
        "description": "As of 21 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to Sales ratio of 1.25. In comparison, peer Crawford & Co. has a higher P/E ratio of 17.88, while GoHealth, Inc. shows a significantly lower P/E of 2.12, highlighting the varying valuations within the industry.\n\nDespite the recent downgrade in valuation, Kingstone's stock has outperformed the S&P 500 over the last three years, with a remarkable return of 1483.87% compared to the S&P 500's 67.17%. However, the year-to-date performance shows a decline of 3.03% against the S&P 500's gain of 12.26%, suggesting that while the long-term outlook has been strong, recent performance may warrant caution...."
      },
      {
        "title": "Is Kingstone Cos., Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kingstone-cos-inc-overvalued-or-undervalued-3711424",
        "imagepath": "",
        "date": "2025-11-18 11:13:53",
        "description": "As of 14 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 11, a price to book value of 2.87, and an EV to EBITDA of 76.30. In comparison to peers, Crawford & Co. has a higher P/E ratio of 17.88, while GoHealth, Inc. shows a significantly lower P/E of 2.12, indicating that Kingstone is positioned in the middle of its peer group.\n\nDespite the fair valuation, Kingstone's recent performance against the S&P 500 is not available for analysis, which limits the ability to draw conclusions about its relative market performance. Overall, the current valuation suggests that Kingstone Cos., Inc. is neither undervalued nor overvalued, aligning closely with its peers in the capital markets industry...."
      },
      {
        "title": "Is Kingstone Cos., Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kingstone-cos-inc-overvalued-or-undervalued-3706948",
        "imagepath": "",
        "date": "2025-11-17 11:08:03",
        "description": "As of 14 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to EBITDA of 76.30, which are significantly higher than its peers like GoHealth, Inc. with a P/E of 2.12 and an EV to EBITDA of 0.42. \n\nIn comparison to the S&P 500, Kingstone has shown a strong performance over the 3-year period with a return of 768.28%, but it has underperformed year-to-date with a return of -5.40% compared to the S&P 500's 14.49%. Overall, the combination of the valuation metrics and peer comparisons suggests that Kingstone Cos., Inc. is currently overvalued...."
      },
      {
        "title": "Is Kingstone Cos., Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kingstone-cos-inc-overvalued-or-undervalued-3705588",
        "imagepath": "",
        "date": "2025-11-16 11:04:52",
        "description": "As of 14 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair. The company appears to be overvalued given its current metrics, including a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to EBITDA of 76.30. In comparison, peers such as Crawford & Co. have a P/E of 17.88 and an EV to EBITDA of 4.11, indicating that Kingstone is trading at a premium relative to its industry.\n\nDespite a strong one-year return of 33.06% compared to the S&P 500's 13.19%, the company's year-to-date performance of -5.40% against the S&P's 14.49% suggests a struggle to maintain momentum. Overall, the combination of valuation ratios and peer comparisons supports the conclusion that Kingstone Cos., Inc. is currently overvalued...."
      }
    ],
    "total": 15,
    "sid": "1156598",
    "stock_news_url": "https://www.marketsmojo.com/news/kingstone-cos-inc-1156598"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Kingstone Cos., Inc. overvalued or undervalued?

2025-11-25 11:15:03

As of 21 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to Sales ratio of 1.25. In comparison to peers, Crawford & Co. has a higher P/E of 17.88, while GoHealth, Inc. shows a significantly lower P/E of 2.12, indicating that Kingstone is positioned between these two companies in terms of valuation. While Kingstone has experienced a remarkable 3-year return of 1520.70%, it has underperformed relative to the S&P 500 over the past year, with a return of -2.64% compared to the index's 11.00%. This suggests that although the company has had strong historical performance, its current valuation does not reflect the same growth potential moving forward....

Read full news article

Is Kingstone Cos., Inc. overvalued or undervalued?

2025-11-23 11:10:45

As of 21 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to Sales ratio of 1.25. In comparison, peer Crawford & Co. has a higher P/E ratio of 17.88, while GoHealth, Inc. shows a significantly lower P/E of 2.12, highlighting the varying valuations within the industry. Despite the recent downgrade in valuation, Kingstone's stock has outperformed the S&P 500 over the last three years, with a remarkable return of 1483.87% compared to the S&P 500's 67.17%. However, the year-to-date performance shows a decline of 3.03% against the S&P 500's gain of 12.26%, suggesting that while the long-term outlook has been strong, recent performance may warrant caution....

Read full news article

Is Kingstone Cos., Inc. overvalued or undervalued?

2025-11-18 11:13:53

As of 14 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 11, a price to book value of 2.87, and an EV to EBITDA of 76.30. In comparison to peers, Crawford & Co. has a higher P/E ratio of 17.88, while GoHealth, Inc. shows a significantly lower P/E of 2.12, indicating that Kingstone is positioned in the middle of its peer group. Despite the fair valuation, Kingstone's recent performance against the S&P 500 is not available for analysis, which limits the ability to draw conclusions about its relative market performance. Overall, the current valuation suggests that Kingstone Cos., Inc. is neither undervalued nor overvalued, aligning closely with its peers in the capital markets industry....

Read full news article

Is Kingstone Cos., Inc. overvalued or undervalued?

2025-11-17 11:08:03

As of 14 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to EBITDA of 76.30, which are significantly higher than its peers like GoHealth, Inc. with a P/E of 2.12 and an EV to EBITDA of 0.42. In comparison to the S&P 500, Kingstone has shown a strong performance over the 3-year period with a return of 768.28%, but it has underperformed year-to-date with a return of -5.40% compared to the S&P 500's 14.49%. Overall, the combination of the valuation metrics and peer comparisons suggests that Kingstone Cos., Inc. is currently overvalued....

Read full news article

Is Kingstone Cos., Inc. overvalued or undervalued?

2025-11-16 11:04:52

As of 14 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair. The company appears to be overvalued given its current metrics, including a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to EBITDA of 76.30. In comparison, peers such as Crawford & Co. have a P/E of 17.88 and an EV to EBITDA of 4.11, indicating that Kingstone is trading at a premium relative to its industry. Despite a strong one-year return of 33.06% compared to the S&P 500's 13.19%, the company's year-to-date performance of -5.40% against the S&P's 14.49% suggests a struggle to maintain momentum. Overall, the combination of valuation ratios and peer comparisons supports the conclusion that Kingstone Cos., Inc. is currently overvalued....

Read full news article

View All News